Abbott Laboratories (ABT) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Abbott Laboratories Revenue Highlights

Latest Revenue (Y)

$41.95B

Latest Revenue (Q)

$11.14B

Main Segment (Y)

Medical Devices

Main Geography (Y)

UNITED STATES

Abbott Laboratories Revenue by Period

Abbott Laboratories Revenue by Year

Date	Revenue	Change
2024-12-31	$41.95B	4.59%
2023-12-31	$40.11B	-8.12%
2022-12-31	$43.65B	1.34%
2021-12-31	$43.08B	24.47%
2020-12-31	$34.61B	8.48%
2019-12-31	$31.90B	4.34%
2018-12-31	$30.58B	11.64%
2017-12-31	$27.39B	31.35%
2016-12-31	$20.85B	2.20%
2015-12-31	$20.41B	0.78%
2014-12-31	$20.25B	-7.33%
2013-12-31	$21.85B	-45.21%
2012-12-31	$39.87B	2.63%
2011-12-31	$38.85B	10.48%
2010-12-31	$35.17B	14.31%
2009-12-31	$30.77B	4.19%
2008-12-31	$29.53B	13.94%
2007-12-31	$25.91B	15.30%
2006-12-31	$22.48B	0.62%
2005-12-31	$22.34B	13.51%
2004-12-31	$19.68B	-0.00%
2003-12-31	$19.68B	11.29%
2002-12-31	$17.68B	8.59%
2001-12-31	$16.29B	18.47%
2000-12-31	$13.75B	4.31%
1999-12-31	$13.18B	5.61%
1998-12-31	$12.48B	5.00%
1997-12-31	$11.88B	7.90%
1996-12-31	$11.01B	10.00%
1995-12-31	$10.01B	9.35%
1994-12-31	$9.16B	8.90%
1993-12-31	$8.41B	-

Abbott Laboratories generated $41.95B in revenue during NA 2024, up 4.59% compared to the previous quarter, and up 131.49% compared to the same period a year ago.

Abbott Laboratories Revenue by Quarter

Date	Revenue	Change
2025-06-30	$11.14B	7.57%
2025-03-31	$10.36B	-5.61%
2024-12-31	$10.97B	3.19%
2024-09-30	$10.63B	2.49%
2024-06-30	$10.38B	4.14%
2024-03-31	$9.96B	-2.70%
2023-12-31	$10.24B	0.97%
2023-09-30	$10.14B	1.65%
2023-06-30	$9.98B	2.37%
2023-03-31	$9.75B	-3.41%
2022-12-31	$10.09B	-3.06%
2022-09-30	$10.41B	-7.52%
2022-06-30	$11.26B	-5.36%
2022-03-31	$11.89B	3.72%
2021-12-31	$11.47B	4.94%
2021-09-30	$10.93B	6.90%
2021-06-30	$10.22B	-2.23%
2021-03-31	$10.46B	-2.29%
2020-12-31	$10.70B	20.87%
2020-09-30	$8.85B	20.81%
2020-06-30	$7.33B	-5.15%
2020-03-31	$7.73B	-7.07%
2019-12-31	$8.31B	2.95%
2019-09-30	$8.08B	1.22%
2019-06-30	$7.98B	5.89%
2019-03-31	$7.54B	-2.96%
2018-12-31	$7.76B	1.42%
2018-09-30	$7.66B	-1.43%
2018-06-30	$7.77B	5.10%
2018-03-31	$7.39B	-2.62%
2017-12-31	$7.59B	11.13%
2017-09-30	$6.83B	2.89%
2017-06-30	$6.64B	4.77%
2017-03-31	$6.33B	18.79%
2016-12-31	$5.33B	0.58%
2016-09-30	$5.30B	-0.58%
2016-06-30	$5.33B	9.17%
2016-03-31	$4.88B	-5.84%
2015-12-31	$5.19B	0.74%
2015-09-30	$5.15B	-0.39%
2015-06-30	$5.17B	5.57%
2015-03-31	$4.90B	-7.43%
2014-12-31	$5.29B	3.64%
2014-09-30	$5.10B	-8.05%
2014-06-30	$5.55B	5.85%
2014-03-31	$5.24B	-7.27%
2013-12-31	$5.65B	5.32%
2013-09-30	$5.37B	-1.41%
2013-06-30	$5.45B	1.27%
2013-03-31	$5.38B	-50.37%
2012-12-31	$10.84B	10.88%
2012-09-30	$9.77B	-0.35%
2012-06-30	$9.81B	3.71%
2012-03-31	$9.46B	-8.87%
2011-12-31	$10.38B	5.71%
2011-09-30	$9.82B	2.08%
2011-06-30	$9.62B	6.36%
2011-03-31	$9.04B	-9.30%
2010-12-31	$9.97B	14.91%
2010-09-30	$8.67B	-1.72%
2010-06-30	$8.83B	14.65%
2010-03-31	$7.70B	-12.42%
2009-12-31	$8.79B	13.26%
2009-09-30	$7.76B	3.56%
2009-06-30	$7.49B	11.56%
2009-03-31	$6.72B	-15.50%
2008-12-31	$7.95B	6.04%
2008-09-30	$7.50B	2.51%
2008-06-30	$7.31B	8.11%
2008-03-31	$6.77B	-6.31%
2007-12-31	$7.22B	-

Abbott Laboratories generated $11.14B in revenue during Q2 2025, up 7.57% compared to the previous quarter, and up 111.82% compared to the same period a year ago.

Abbott Laboratories Revenue Breakdown

Abbott Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Medical Devices	$18.99B	$16.89B	$14.69B	$435.00M	$430.00M
Established Pharmaceutical Products	$5.19B	$5.07B	$4.91B	$4.72B	$4.30B
Diagnostic Products	$9.34B	$9.99B	$16.58B	$4.00B	$3.80B
Nutritional Products	$8.41B	$8.15B	$7.46B	$8.29B	$7.65B

Abbott Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 24: Medical Devices (45.28%), Diagnostic Products (22.28%), Nutritional Products (20.06%), and Established Pharmaceutical Products (12.39%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Diagnostic Products	$5.90B	$2.05B	-	$5.30B	$4.80B	$4.50B	-	$4.20B	$4.20B	$4.10B	$3.90B	$3.90B	$3.80B	$4.47B	$3.90B	$3.90B	$3.80B	$4.34B	$3.60B	$3.50B
Established Pharmaceutical Products	$1.38B	$1.26B	$1.27B	$1.41B	$1.29B	$1.23B	$1.22B	$1.37B	$1.15B	$1.20B	$1.26B	$1.18B	$1.07B	$1.15B	$1.10B	$1.01B	-	-	-	-
Medical Devices	$5.37B	$4.89B	$5.05B	$4.75B	$4.73B	$4.45B	$4.44B	$4.25B	$475.00M	$450.00M	$433.00M	$436.00M	$428.00M	$3.75B	$445.00M	$414.00M	$400.00M	$3.26B	$430.00M	$415.00M
Nutritional Products	$2.21B	$2.15B	$2.13B	$2.07B	$2.15B	$2.07B	$2.04B	$2.07B	$1.89B	$2.04B	$2.11B	$2.11B	$2.04B	$1.94B	$1.92B	$1.88B	-	-	-	-
Other Segment	-	-	-	-	-	-	-	-	-	-	-	-	$3.00M	$3.00M	$11.00M	-	-	-	-	-
All Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$22.00M	$16.00M	$16.00M	$20.00M	$15.00M

Abbott Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Diagnostic Products (39.69%), Medical Devices (36.12%), Nutritional Products (14.88%), and Established Pharmaceutical Products (9.30%).

Abbott Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
GERMANY	$2.54B	$2.35B	$2.34B	-	-
INDIA	$1.82B	$1.75B	$1.65B	-	-
JAPAN	$1.44B	$1.51B	$1.93B	-	-
NETHERLANDS	$1.12B	$1.07B	-	-	-
SWITZERLAND	$1.75B	$1.64B	$1.34B	-	-
UNITED STATES	$16.32B	$15.45B	$18.14B	-	-
Non-US	$14.85B	$14.08B	$14.84B	-	-
C [H]	$2.11B	$2.25B	-	-	-
CHINA	-	$2.25B	$2.13B	-	-
CANADA	-	-	$1.28B	-	-
All Other Countries	-	-	$14.84B	$15.52B	-
Switzerland	-	-	-	$1.31B	-
Canada	-	-	-	$1.39B	-
China	-	-	-	$2.39B	-
Germany	-	-	-	$2.57B	-
India	-	-	-	$1.56B	-
Japan	-	-	-	$1.70B	-
Other Countries	-	-	-	-	$12.58B
N	-	-	-	-	$1.08B
J	-	-	-	-	$1.39B
I	-	-	-	-	$1.32B
D	-	-	-	-	$2.11B
C	-	-	-	-	$1.14B

Abbott Laboratories's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (38.91%), Non-US (35.39%), GERMANY (6.05%), C [H] (5.04%), INDIA (4.33%), SWITZERLAND (4.16%), JAPAN (3.44%), and NETHERLANDS (2.68%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 18
Non-US	$6.87B	$6.19B	-	$6.43B	$6.44B	$6.12B	-	$6.33B	$6.22B	$5.82B	$5.87B	$6.32B	$6.37B	-
UNITED STATES	$4.28B	$4.17B	$4.34B	$4.20B	$3.93B	$3.85B	$3.95B	$3.82B	$3.76B	$3.93B	$4.22B	$4.09B	$4.89B	-
Medical Devices	-	$4.89B	-	-	-	-	-	-	-	-	-	-	-	-
Established Pharmaceutical Products	-	$1.26B	-	-	-	-	-	-	-	-	-	-	-	-
Diagnostic Products	-	$2.05B	-	-	-	-	-	-	-	-	-	-	-	-
Nutritional Products	-	$2.15B	-	-	-	-	-	-	-	-	-	-	-	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	$336.00M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	$94.00M

Abbott Laboratories's latest quarterly revenue breakdown by geography, as of Jun 25: Non-US (61.62%), and UNITED STATES (38.38%).

Abbott Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
UNH	UnitedHealth Group	$400.28B	$113.16B
NVO	Novo Nordisk	$232.26B	$65.35B
MRK	Merck	$64.17B	$15.81B
NVS	Novartis	$46.66B	$11.83B
AZN	AstraZeneca	$45.81B	$12.68B
TMO	Thermo Fisher Scientific	$42.88B	$10.86B
ABT	Abbott Laboratories	$41.95B	$11.14B
MDT	Medtronic	$33.54B	$8.58B
GILD	Gilead Sciences	$28.75B	$6.67B
SYK	Stryker	$22.59B	$6.02B
BSX	Boston Scientific	$16.75B	$5.06B

ABT Revenue FAQ

What is Abbott Laboratories’s yearly revenue?

Abbott Laboratories's yearly revenue for 2024 was $41.95B, representing an increase of 4.59% compared to 2023. The company's yearly revenue for 2023 was $40.11B, representing a decrease of -8.12% compared to 2022. ABT's yearly revenue for 2022 was $43.65B, representing an increase of 1.34% compared to 2021.

What is Abbott Laboratories’s quarterly revenue?

Abbott Laboratories's quarterly revenue for Q2 2025 was $11.14B, a 7.57% increase from the previous quarter (Q1 2025), and a 7.37% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $10.36B, a -5.61% decrease from the previous quarter (Q4 2024), and a 3.95% increase year-over-year (Q1 2024). ABT's quarterly revenue for Q4 2024 was $10.97B, a 3.19% increase from the previous quarter (Q3 2024), and a 7.16% increase year-over-year (Q4 2023).

What is Abbott Laboratories’s revenue growth rate?

Abbott Laboratories's revenue growth rate for the last 3 years (2022-2024) was -3.90%, and for the last 5 years (2020-2024) was 21.21%.

What are Abbott Laboratories’s revenue streams?

Abbott Laboratories's revenue streams in c 24 are Medical Devices, Established Pharmaceutical Products, Diagnostic Products, and Nutritional Products. Medical Devices generated $18.99B in revenue, accounting 45.28% of the company's total revenue, up 12.43% year-over-year. Established Pharmaceutical Products generated $5.19B in revenue, accounting 12.39% of the company's total revenue, up 2.53% year-over-year. Diagnostic Products generated $9.34B in revenue, accounting 22.28% of the company's total revenue, down -6.48% year-over-year. Nutritional Products generated $8.41B in revenue, accounting 20.06% of the company's total revenue, up 3.18% year-over-year.

What is Abbott Laboratories’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Abbott Laboratories was Medical Devices. This segment made a revenue of $18.99B, representing 45.28% of the company's total revenue.